Activation of GPR120 by TUG891 ameliorated cisplatin-induced acute kidney injury via repressing ER stress and apoptosis
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 126, 110056
Abstract
No abstract availableKeywords
Funding Information
- Sichuan University (Z2018B15)
This publication has 27 references indexed in Scilit:
- GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acidsJournal of Hepatology, 2014
- 4-Phenylbutyrate Inhibits Tunicamycin-Induced Acute Kidney Injury via CHOP/GADD153 RepressionPLOS ONE, 2014
- The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic AgonismMolecular Pharmacology, 2013
- Endoplasmic Reticulum and the Unfolded Protein Response2013
- Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and humanNature, 2012
- The Unfolded Protein Response: From Stress Pathway to Homeostatic RegulationScience, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- The nephrotoxicity of cisplatinLife Sciences, 1983